Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ana Isabel López López, MD
Hospital Clínico Universitario San Juan (SPAIN)
Principal Investigator - José David Jiménez Parra, MD
Hospital Rafael Méndez (Lorca, Murcia. SPAIN)
Principal Investigator - José Felix Escudero Bregante, MD
Hospital Clínico Universitario Virgen de la Arrixaca (SPAIN)
Principal Investigator - Julián Oñate, MD
Hospital General Universitario Reina Sofía (SPAIN)
Principal Investigator - María Luisa María Luisa, MD
Hospital Clínica Universitario Virgen de la Arrixaca (SPAIN)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Clínico Universtario Virgen de la Arrixaca
El Palmar, Murcia, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 May 2018
- Primary completion
- 31 Mar 2019
- Completion
- 31 Mar 2019
- Last update posted
- 2 Aug 2018
- Registered enrollment
- 110
- Registry id
- NCT03468465
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.